Inventor · disambiguated record
Tong-Ho Lin
Also filed as: LIN TONG · LIN TONG-HO
7 granted patents·4 pending applications·11 citations·filing 2005–2020
78Inventor score
Files withALAR PHARMACEUTICALS INC4TELOMERASE ACTIVATION SCIENCES INC3LOTUS PHARMACEUTICAL CO LTD2ALAR PHARMACEUTICAL INC1HARLEY CALVIN B1
Top patents by PatentIndex Score
11 records- 0179US8481721B2Compositions and methods for increasing telomerase activityHARLEY CALVIN B·Filed 2010·Granted Jul 9, 2013·5 cites·25 claims
- 0272US11524965B2Long-acting injectable formulations and crystalline forms of buprenorphine derivativesALAR PHARMACEUTICALS INC·Filed 2019·Granted Dec 13, 2022·1 cites·8 claims
- 0372US9403866B2Compositions and methods for increasing telomerase activityTELOMERASE ACTIVATION SCIENCES INC·Filed 2013·Granted Aug 2, 2016·2 cites·13 claims
- 0468US9913851B2Compositions and methods for increasing telomerase activityTELOMERASE ACTIVATION SCIENCES INC·Filed 2015·Granted Mar 13, 2018·1 cites·12 claims
- 0566US10744132B2Sustained-release buprenorphine formulationsALAR PHARMACEUTICALS INC·Filed 2017·Granted Aug 18, 2020·2 cites·7 claims
- 0655US11981617B2Ketamine pamoate and use thereofALAR PHARMACEUTICALS INC·Filed 2020·Granted May 14, 2024·0 cites·13 claims
- 0753US2018280413A1Compositions and Methods For Increasing Telomerase ActivityTELOMERASE ACTIVATION SCIENCES INC·Filed 2017·Application pending·0 cites
- 0846US2010172986A1Controlled release composition and preparation thereofLOTUS PHARMACEUTICAL CO LTD·Filed 2006·Application pending·0 cites
- 0942US2024099994A1Long-acting injectable formulations of ketamine pamoate saltsALAR PHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 1037US12201630B2Naltrexone injectable sustained release formulationALAR PHARMACEUTICALS INC·Filed 2019·Granted Jan 21, 2025·0 cites·6 claims
- 1133US2005220715A1Methods and compositions for improving drug safetyLOTUS PHARMACEUTICAL CO LTD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tong-Ho Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →